Korean Circ J.
2023 May;53(5):328-330. 10.4070/kcj.2023.0039.
Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Cardiovascular Center, Seoul St. Mary’s Hospital, Seoul, Korea
- KMID: 2542302
- DOI: http://doi.org/10.4070/kcj.2023.0039
Cited by 1 articles
-
A Single Center Experience of Pulmonary Arterial Hypertension Management in Korea: A 25-Year Comparative Analysis Following the Introduction of Targeted Therapy
Ji Hyun Cha, Shin Yi Jang, Jinyoung Song, I-Seok Kang, June Huh, Taek Kyu Park, Jeong Hoon Yang, Seung Woo Park, Hojoong Kim, Duk-Kyung Kim, Sung-A Chang
Korean Circ J. 2024;54(10):636-650. doi: 10.4070/kcj.2023.0316.
Reference
-
1. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019; 53:1801913. PMID: 30545968.
Article2. Maron BA, Hess E, Maddox TM, et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program. Circulation. 2016; 133:1240–1248. PMID: 26873944.
Article3. Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022; 327:1379–1391. PMID: 35412560.
Article4. Galiè N, Barberà JA, Frost AE, et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015; 373:834–844. PMID: 26308684.
Article5. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115:343–349. PMID: 1863023.6. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest. 2012; 142:448–456. PMID: 22281797.
Article7. Jang AY, Lee H, Kim HC, Chung JW. Epidemiology of targeted therapy-treated PAH in Korea: an analysis of the national health insurance data, 2002-2018. Korean Circ J. 2023; 53:313–327. PMID: 37161745.
Article8. Lim SS, Lee W, Kim YK, et al. The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015. Orphanet J Rare Dis. 2019; 14:49. PMID: 30777110.
Article
